Comparative Analysis of Insulin-like Growth Factor I and Tumour-associated Antigens in Cancer Patients at the Time of Diagnosis

Anonymous (2002). Revision I. Version 4 x Y, Diagnostic Products Corporation, USA.Search in Google Scholar

Brooks, M. (2009). Breast cancer screening and biomarkers. Surg. Oncol., 18(1), 15-24.10.1007/978-1-60327-492-0_1319107439Search in Google Scholar

Carpelan-Holmström, M., Louhimo, J., Stenman, U.H., Alfthan, H., Haglund, C. (2002). CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res. 22(4), 2311-2316.Search in Google Scholar

Chen, C.C., Yang, S.H., Lin, J.K., Lin, T.C., Chen, W.S., Jiang, J.K., Wang, H.S., Chang, S.C. (2005). Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer? J. Surg. Res., 124(2), 169-74.10.1016/j.jss.2004.08.01315820244Search in Google Scholar

Dbouk, H.A., Tawil, A., Nasr, F., Kandakarjian, L., Abou-Merhi, R. (2007). Significance of CEA and VEGF as Diagnostic Markers of Colorectal Cancer in Lebanese Patients. Open Clin. Cancer J., 1, 1-5.10.2174/1874189400701010001249059818665243Search in Google Scholar

Delarue, J.C., Mouriesse, H., Dubois, F., Friedman, S., May-Levin, F. (1988). Markers in breast cancer: Does CEA add to the detection by CA 15.3? Breast Cancer Res. Treat., 11(3), 273-276.10.1007/BF018072873167234Search in Google Scholar

DeLellis, K., Ingles, S., Kolonel, L., McKean-Cowdin, R., Henderson, B., Stanczyk, F., Probst-Hensch, N.M. (2003). IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort. Brit. J. Cancer, 88(2), 277-282.10.1038/sj.bjc.6600728237703612610514Search in Google Scholar

Durai, R., Yang, W., Gupta, S., Seifalian, A.M., Winslet, M.C. (2005). The role of the insulin-like growth factor system in colorectal cancer: Review of current knowledge. Int. J. Colorectal Dis., 20(3), 203-220.10.1007/s00384-004-0675-415650828Search in Google Scholar

Fernandes, L.C., Kim, S.B., Matos, D. (2005). Cytokeratins and carcino-embryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma. World J. Gastroenterol., 11(5), 645-648.10.3748/wjg.v11.i5.645425073115655814Search in Google Scholar

Fürstenberger, G., Morant, R., Senn, H.J. (2003). Insulin-like growth factors and breast cancer. Onkologie, 26(3), 290-294.Search in Google Scholar

Hankinson, S.E., Willett, W.C., Colditz, G.A., Hunter, D.J., Michaud, D.S., Deroo, B., Rosner, B., Speizer, F.E., Pollak, M. (1998). Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet, 351(9113), 1393-1396.Search in Google Scholar

Holly, J.M., Gunnell, D.J., Davey Smith, G. (1999). Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J. Endocrinol., 162(3), 321-330.Search in Google Scholar

Jenkins, P.J., Bustin, S.A. (2004). Evidence for a link between IGF-I and cancer. Eur. J. Endocrinol., 151 (Suppl 1), S17-22.10.1530/eje.0.151s01715339239Search in Google Scholar

Johansson, H., Baglietto, L., Guerrieri-Gonzaga, A., Bonanni, B., Mariette, F., Macis, D., Serrano, D., Sandri, M.T., Decensi, A. (2004). Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer. Breast Cancer Res. Treat., 88(1), 63-73.10.1007/s10549-004-0746-915538047Search in Google Scholar

Kaczka, A., Kumor, A., Pietruczuk, M., Malecka-Panas, E. (2007). Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer. Pol. Merkur Lekarski, 22(131), 373-375 (in Polish)Search in Google Scholar

Morimoto, L.M., Newcomb1, P.A., White, E., Bigler, J., Potter, J.D. (2005). Insulin-like growth factor polymorphisms and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prevent., 14, 1204-1211.10.1158/1055-9965.EPI-04-069515894673Search in Google Scholar

Duffy, M.J. (2001). Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is it clinically useful? Clinical Chemistry, 47, 624-630.10.1093/clinchem/47.4.624Search in Google Scholar

Renehan, A.G., Zwahlen, M., Minder, C., O'Dwyer, S.T., Shalet, S.M., Egger, M. (2004). Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: Systematic review and meta-regression analysis. Lancet, 363(9418), 1346-1353.Search in Google Scholar

Schiemann, U., Günther, S., Gross, M., Henke, G., Müller-Koch, Y., König, A., Muders, M., Folwaczny, C., Mussack, T., Holinski-Feder, E. (2005). Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer. Cancer Detect. Prev., 29(4), 356-360.10.1016/j.cdp.2005.04.00316122885Search in Google Scholar

Tan, E., Gouvas, N., Nicholls, R.J., Ziprin, P., Xynos, E., Tekkis, P.P. (2009). Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Methods Mol. Biol., 472, 307-321.10.1016/j.suronc.2008.05.00818619834Search in Google Scholar

Tripkovic, I., Tripkovic, A., Strnad, M., Capkun, V., Zekan, L. (2007). Role of insulin-like growth factor-1 in colon cancerogenesis: A case-control study. Arch. Med. Res., 38(5), 519-525.10.1016/j.arcmed.2007.01.01217560457Search in Google Scholar